GoldenGolden

Zhengzhou Granlen PharmaTech

A chemistry-based contract research organization that provides chemistry-related services for biotech, pharmaceutical, and diagnostic industries.

Zhengzhou Granlen PharmaTech is a multinational chemistry-based contract research organization that offers an integrated discovery and development platform for the biotech and pharmaceutical industries. Their state of the art research facilities and head office are located in Zhengzhou, China. The company also has offices in San Diego, California. Granlen's chemistry and related teams offer made to order compound libraries, hit-to-lead optimization, medicinal chemistry, and a wide range of chemistry-related services including custom synthesis, intermediates, reference compounds, metabolites and impurities, route scouting, process development, and scale-up as well as analytical method development, quality control, and others for investigational new drug preparation.

Covid-19 Treatment

As of February 2020, clinical trials are ongoing to repurpose Zhengzhou Granlen PharmaTech's Azvudine drug, an experimental reverse transcriptase inhibitor drug against HIV-1/AIDS, to treat Covid-19.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.